These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21735842)

  • 21. [HPV vaccination and cervical cancer screening].
    Sigurdsson K
    Laeknabladid; 2007 Dec; 93(12):819, 821. PubMed ID: 18057470
    [No Abstract]   [Full Text] [Related]  

  • 22. [Diseases caused by human papilloma viruses].
    Zollner U; Schwarz TF
    Dtsch Med Wochenschr; 2011 May; 136(20):1067-72. PubMed ID: 21560109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of
    Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Harjula K; Kuortti M; Natunen K; Palmroth J; Petäjä T; Pukkala E; Siitari-Mattila M; Struyf F; Nieminen P; Paavonen J; Dubin G; Dillner J
    BMJ Open; 2017 Aug; 7(8):e015867. PubMed ID: 28821519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Who should be targeted for vaccination against anal cancer?
    Harper DM; Vierthaler SL
    Lancet Oncol; 2011 Sep; 12(9):828-9. PubMed ID: 21865086
    [No Abstract]   [Full Text] [Related]  

  • 25. Cost-effectiveness of human papillomavirus vaccine in reducing the risk of cervical cancer in Ireland due to HPV types 16 and 18 using a transmission dynamic model.
    Usher C; Tilson L; Olsen J; Jepsen M; Walsh C; Barry M
    Vaccine; 2008 Oct; 26(44):5654-61. PubMed ID: 18723068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cervical cancer: Current situation and management in Morocco].
    Belglaiaa E; Mougin C
    Bull Cancer; 2019 Nov; 106(11):1008-1022. PubMed ID: 31606139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Papillomavirus vaccine types 16 and 18: new drug. Cervical cancer: just another vaccine.
    Prescrire Int; 2008 Jun; 17(95):103-4. PubMed ID: 18623911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-appropriate use of human papillomavirus vaccines in the U.S.
    Castle PE; Fetterman B; Akhtar I; Husain M; Gold MA; Guido R; Glass AG; Kinney W
    Gynecol Oncol; 2009 Aug; 114(2):365-9. PubMed ID: 19464729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
    Hantz S; Alain S; Denis F
    Gynecol Obstet Fertil; 2006; 34(7-8):647-55. PubMed ID: 16807045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study.
    Skinner SR; Szarewski A; Romanowski B; Garland SM; Lazcano-Ponce E; Salmerón J; Del Rosario-Raymundo MR; Verheijen RH; Quek SC; da Silva DP; Kitchener H; Fong KL; Bouchard C; Money DM; Ilancheran A; Cruickshank ME; Levin MJ; Chatterjee A; Stapleton JT; Martens M; Quint W; David MP; Meric D; Hardt K; Descamps D; Geeraerts B; Struyf F; Dubin G;
    Lancet; 2014 Dec; 384(9961):2213-27. PubMed ID: 25189358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008-2015.
    Cleveland AA; Gargano JW; Park IU; Griffin MR; Niccolai LM; Powell M; Bennett NM; Saadeh K; Pemmaraju M; Higgins K; Ehlers S; Scahill M; Johnson Jones ML; Querec T; Markowitz LE; Unger ER;
    Int J Cancer; 2020 Feb; 146(3):810-818. PubMed ID: 30980692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the interim analysis from the PATRICIA study group: efficacy of a vaccine against HPV 16 and 18.
    Frederick PJ; Huh WK;
    Expert Rev Anticancer Ther; 2008 May; 8(5):701-5. PubMed ID: 18471043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of HPV-16/18 AS04-adjuvanted vaccine on preventing subsequent infection and disease after excision treatment: post-hoc analysis from a randomized controlled trial.
    Zhao S; Hu S; Xu X; Zhang X; Pan Q; Chen F; Zhao F
    BMC Infect Dis; 2020 Nov; 20(1):846. PubMed ID: 33198657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cervical cancer vaccination: the real meaning of cross-protection and its impact on the prevention.
    De Carvalho NS
    Vaccine; 2008 Nov; 26(50):6293-4. PubMed ID: 18804508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial.
    Apter D; Wheeler CM; Paavonen J; Castellsagué X; Garland SM; Skinner SR; Naud P; Salmerón J; Chow SN; Kitchener HC; Teixeira JC; Jaisamrarn U; Limson G; Szarewski A; Romanowski B; Aoki FY; Schwarz TF; Poppe WA; Bosch FX; Mindel A; de Sutter P; Hardt K; Zahaf T; Descamps D; Struyf F; Lehtinen M; Dubin G;
    Clin Vaccine Immunol; 2015 Apr; 22(4):361-73. PubMed ID: 25651922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of vaccination with Cervarix (trade mark) on subsequent HPV-16/18 infection and cervical disease in women 15-25 years of age.
    Harper DM
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S11-7. PubMed ID: 18649932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination protects against invasive HPV-associated cancers.
    Luostarinen T; Apter D; Dillner J; Eriksson T; Harjula K; Natunen K; Paavonen J; Pukkala E; Lehtinen M
    Int J Cancer; 2018 May; 142(10):2186-2187. PubMed ID: 29280138
    [No Abstract]   [Full Text] [Related]  

  • 38. [Well-founded role of HPV analysis in cervix cancer prevention].
    Johansson BC; Andersson S; Hjerpe A
    Lakartidningen; 2007 Feb 21-27; 104(8):608; author reply 608-9. PubMed ID: 17396462
    [No Abstract]   [Full Text] [Related]  

  • 39. Frequent high-risk HPV co-infections excluding types 16 or 18 in cervical neoplasia in Guadeloupe.
    Gaete S; Auguste A; Bhakkan B; Peruvien J; Herrmann-Storck C; Socrier Y; Diedhiou A; Deloumeaux J
    BMC Cancer; 2021 Mar; 21(1):281. PubMed ID: 33726684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [HPV immunization for the prevention of cervical cancer].
    Mougin C; Bourgault-Villada I; Coursaget P
    Presse Med; 2009 Dec; 38(12):1750-68. PubMed ID: 19765945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.